Severe Symptoms Persist for Up to One Year After Diagnosis of Stage I-III Lung Cancer: An Analysis of Province-Wide Patient Reported Outcomes

Lung cancer is the most common cancer worldwide, accounting for approximately 17% and 9% of all cancers in men and women, respectively, and more than 1.6 million cancer-related deaths every year [1]. Patients with non-metastatic disease are eligible for curative treatment, which can include various combinations of surgery, chemotherapy and radiotherapy [2 –4]. The risk of experiencing major morbidity from surgery ranges from 10%-30% and most common symptomatic complications include arrhythmias, pneumonia and pulmonary embolism [5].

Source: Lung Cancer - February 24, 2020 Category: Cancer & Oncology Authors: Dhruvin H. Hirpara, Vaibhav Gupta, Laura E. Davis, Haoyu Zhao, Julie Hallet, Alyson L. Mahar, Rinku Sutradhar, Mark Doherty, Alexander V. Louie, Biniam Kidane, Gail Darling, Natalie G. Coburn Source Type: research